期刊文献+

视黄醇结合蛋白和血清胱抑素C以及同型半胱氨酸在糖尿病肾损伤患者中的检测意义 被引量:6

Study on the Significant of Serum Cystatin C and Hcy and RBP in Diabetic Nephropathy
下载PDF
导出
摘要 目的:探讨视黄醇结合蛋白和胱抑素C以及同型半胱氨酸在糖尿病肾损伤患者早期检测的意义。方法将80例糖尿病患者按屎清蛋白排泄率(U-rinary albumin excretion rate,UAER)分为3组:A组为正常清蛋白尿组(UAER<20g/min或尿蛋白<30mg/24h)30例;B组,微量清蛋白尿组(UAER为20~200g/rain或尿蛋白30~300mg/24h)28例;C组,临床糖尿病肾病组(UAER>200g/rain或尿蛋白>0.5g/24h)22例。另择40例健康人作为正常对照(NC)组。同时检测血尿视黄醇结合蛋白(RBP)、尿微量清蛋白排泄率(UAER)、胱押素C(CysC)和同型半胱氨酸(Hey),进行相关的统计学分析。结果组问血RBP,UAER,尿RBP,Hcy和CysC值比较差异有统计学显著性意义(P<0.01)。NC组血RBP,UAER,尿RBP,Hey和CysC水平和A组相比差异无统计学显著性意义(P>0.05);均低于B和C组(P<0.01);C组血RBP,UAER,尿RBP,Hcy和CysC水平都高于A和B组(P<0.01);A组和B组相比差异也有统计学显著性意义(P<O.01)。结论RBP和CysC以及Hcy联合检测可以作为鉴另4糖尿病肾损伤患者病变程度的早期指标。 Objective To explore the significance of detection serum Cystatin C(Cys C) and Hyperhomocysteinemia(Hcy)and retinol binding proteinin (RBP) in diabetic nephropathy. Methods 80 diabetic patients with suspected DN were derided into three groups according to detect UAER level, and 40 cases as control group. The patients serum RBP, UAER, Cys C and Hcy were detected by the standard method. Results RI3P,UAER,Cys C and Hcy level in DN group was higher significantly than these in control group (P〈0. 01) ,and these index level have no statistical difference between control group and normal urinary albumin group(A group) (P〉0. 05). However, were higher in minimal urinary albumin group (B group) and DN group (C group) than control group in diagnosis of diabetic nephropathy (P〈0.01). Conclusion RBP, Cys C and Hcy could be a role .indicator for early impairment of renal function for diagnosis of diabetic nephropathy.
出处 《现代检验医学杂志》 CAS 2012年第2期128-129,131,共3页 Journal of Modern Laboratory Medicine
关键词 视黄醇结合蛋白 胱抑素C 高同型半胱氨酸血症 retinol binding proteinin(RBP) Cystatin C(Cys C) hyperhomocysteinemia
  • 相关文献

参考文献5

  • 1Li ZZ, Lu XZ, Liu JB, et al. Serum retinol-binding protein 4 levels in patients with diabetic retinopathy [J]. J Int Med Res,2010,38(1) :95-99.
  • 2Takebayashi K, Suetsugu M, Wakabayashi S, et al. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients [J].J Clin Endocrinol Metab,2007,92(7) :2712-2719.
  • 3Ellis D, Forrest KY, Erbey F, et al. Urinary measu-re- ment of transforming growth factor and type IV col- lagen as new markers of renal injury: application in diabetic nephropathy[J]. J Clin Chem, 1998,44 (5) : 950-956.
  • 4Ozkan Y, Ozkan E, Simsek B. Plasma total homocys- teine and eysteine levels as cardiovascular risk factors in coronary heart disease[J]. Int J Cardiol, 2002,83 (3) :269-277.
  • 5Niskanen LK, Laaksonen DE, Nyyssonen K, et a k U- ric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men:a prospective cohort study[J]. Arch Intern Med, 2004, 164 (14) 1546-1551.

同被引文献48

  • 1Brunetti ND,Pellegrino PL,Gorreale M,et al.Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction[J],.Thromb Thrombolysis,2008,26∶ 197-203.
  • 2Newby AC,George SJ,Ismail Y,et al.Vulnerable atherosclerotic plaque metalloproteinases and foam cell Phenotypes[J],.Thromb Hacmost,2009,101∶ 1006-1011.
  • 3Aoki A,Murata M,Asano T,et al.Prompt increases in retinol-binding protein 4 and endothelial progenitor cells during a-cute exercise load in diabetic subjects [J].Endocr J,2012,59(12):1085-1091.
  • 4Chu CHI,Lam HC,Lee JK,et al.Elevated serum retinol 一binding protein 4 concentrations are associated with chronickidney disease but not with the higher carotid intima-mediathickness in type 2 diabetic subjects [J].Endocr J,2011,58(10):841-847.
  • 5Toruner F,Altinova AE,Akturk M,et al.The relationship be-tween adipocyte fatty acid binding protein-4, retinol bindingprotein-4 levels and early diabetic nephropathy in patientswith type 2 diabetes [J].Diabetes Res Clin Pract,2011,91(2):203-207.
  • 6Papadopoulou-Marketou N,Skevaki C,Kosteria I,et al.NGALand cystatin C: two possible early markers of diabeticnephropathy in young patients with type 1 diabetes melli-tus: one year follow up [J].Hormones (Athens),2015,14(2):232-240.
  • 7Jeon YL,Kim MHl,Lee WI,et al.Cystatin C as an earlymarker of diabetic nephropathy in patients with type 2 dia-betes[J].Clin Lab,2013,59(11-12):1221-1229.
  • 8Triki S,Fekih 0, Hellara I,et al.Association between serumcystatin C levels and cardiovascular disease in type 2 dia-betic patients[J].Ann Biol Clin (Paris),2013,71(4):438-442.
  • 9Oltean S,Qiu Y,Ferguson JK,etal. Vascular EndothelialGrowth Factor -A165b Is Protective and RestoresEndothelial Glycocalyx in Diabetic Nephropathy [J].J AmSoc Nephrol,2014,8(7):96-98.
  • 10Liebon L, Callewaert F, Bouillon tL Bone and metabolism: a com- plex erosstalk. Harm Res,2009,71(Suppl 1) :134-138.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部